🚀 VC round data is live in beta, check it out!
- Public Comps
- Goodwill Pharma
Goodwill Pharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for Goodwill Pharma and similar public comparables like MediClin, Monash IVF Group, Athens Medical Centre, Clinica Las Condes and more.
Goodwill Pharma Overview
About Goodwill Pharma
Goodwill Pharma Nyrt is a full service pharma partner for the CEE region. The company s core activities include pharmaceutical logistics and distribution, pharmaceutical registration, full pharmaceutical marketing services, medical promotion, manufacturer and brand representation, own-licensed product development, manufacturing and marketing of proprietary pharmaceuticals and dietary supplements.
Founded
N/A
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$222M
Goodwill Pharma Financials
Goodwill Pharma reported last fiscal year revenue of $61K and EBITDA of $10K.
In the same fiscal year, Goodwill Pharma generated $20K in gross profit, $10K in EBITDA, and $6K in net income.
Goodwill Pharma P&L
In the most recent fiscal year, Goodwill Pharma reported revenue of $61K and EBITDA of $10K.
Goodwill Pharma expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $61K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $20K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 33% | XXX | XXX | XXX |
| EBITDA | — | XXX | $10K | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 12% | XXX | XXX | XXX |
| Net Profit | — | XXX | $6K | XXX | XXX | XXX |
| Net Margin | — | XXX | 10% | XXX | XXX | XXX |
| Net Debt | — | — | $17K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Goodwill Pharma Stock Performance
Goodwill Pharma has current market cap of $201M, and enterprise value of $222M.
Market Cap Evolution
Goodwill Pharma's stock price is $1.88.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $222M | $201M | 0.0% | XXX | XXX | XXX | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGoodwill Pharma Valuation Multiples
Goodwill Pharma trades at 3639.3x EV/Revenue multiple, and 21777.0x EV/EBITDA.
Goodwill Pharma Financial Valuation Multiples
As of April 19, 2026, Goodwill Pharma has market cap of $201M and EV of $222M.
Equity research analysts estimate Goodwill Pharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Goodwill Pharma has a P/E ratio of 31598.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $201M | XXX | $201M | XXX | XXX | XXX |
| EV (current) | $222M | XXX | $222M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 3639.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 21777.0x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 30285.5x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 11114.4x | XXX | XXX | XXX |
| P/E | — | XXX | 31598.5x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (22558.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Goodwill Pharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Goodwill Pharma Margins & Growth Rates
Goodwill Pharma's revenue in the last fiscal year grew by 18%.
Goodwill Pharma Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 37% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 21% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Goodwill Pharma Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Goodwill Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| MediClin | XXX | XXX | XXX | XXX | XXX | XXX |
| Monash IVF Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| Clinica Las Condes | XXX | XXX | XXX | XXX | XXX | XXX |
| AirSculpt | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Goodwill Pharma M&A Activity
Goodwill Pharma acquired XXX companies to date.
Last acquisition by Goodwill Pharma was on XXXXXXXX, XXXXX. Goodwill Pharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Goodwill Pharma
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialGoodwill Pharma Investment Activity
Goodwill Pharma invested in XXX companies to date.
Goodwill Pharma made its latest investment on XXXXXXXX, XXXXX. Goodwill Pharma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Goodwill Pharma
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Goodwill Pharma
| Where is Goodwill Pharma headquartered? | Goodwill Pharma is headquartered in Hungary. |
| Is Goodwill Pharma publicly listed? | Yes, Goodwill Pharma is a public company listed on Budapest Stock Exchange. |
| What is the stock symbol of Goodwill Pharma? | Goodwill Pharma trades under GOODWILLPHRM ticker. |
| When did Goodwill Pharma go public? | Goodwill Pharma went public in 2022. |
| Who are competitors of Goodwill Pharma? | Goodwill Pharma main competitors are MediClin, Monash IVF Group, Athens Medical Centre, Clinica Las Condes. |
| What is the current market cap of Goodwill Pharma? | Goodwill Pharma's current market cap is $201M. |
| What is the current revenue of Goodwill Pharma? | Goodwill Pharma's last fiscal year revenue is $61K. |
| What is the current EV/Revenue multiple of Goodwill Pharma? | Current revenue multiple of Goodwill Pharma is 3639.3x. |
| Is Goodwill Pharma profitable? | No, Goodwill Pharma is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.